Faculty

Institution

Unit

Venue

Peter Oelschlaeger

Associate Professor

Western University of Health Sciences

Affiliations

College Of Pharmacy

Department Of Pharmaceutical Sciences

Peter Oelschlaeger is currently serving as a College Of Pharmacy Associate Professor at Western University of Health Sciences.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Peter Oelschlaeger

Western University of Health Sciences

Associate Professor

You can click a keyword to filter the displayed items

pharmacology drug discovery enzyme inhibition medicinal chemistry drug resistance medicine protein science drug development antimicrobial agents pharmaceutical chemistry biochemistry biomolecular engineering bioorganic chemistry antimicrobial resistance structural biology clinical microbiology clinical chemistry applied microbiology pharmacological research therapeutic targets drug delivery pharmacotherapy molecular cell biology rational drug design g protein-coupled receptor potent scaffold peptides future medicinal chemistry peptide science molecular science structural molecular biology bone research polyhedron conformational studies combinatorial chemistry metalloproteins remedial action pharmaceutical sciences clinical pharmacology antimicrobial chemotherapy protein evolution protein bioinformatics host specificity biological residue bone metabolism sclerostin bone morphogenic protein antibiotic resistance antimicrobial susceptibility inhibitory activity drug resistance analysis functional selectivity receptor (biochemistry) molecular pathways human polymorphisms pharmacogenomics antihypertensive therapy genetic determinants extended version reactive dynamics promising scaffold inhibitor discovery diaryl-substituted azolylthioacetamides valid scaffold monoclonal antibody therapy broad-spectrum metallo-b-lactamase inhibitors metallo-b-lactamase inhibitors virtual screening broad-spectrum inhibitor imp-type metallo-b-lactamase evolution dna polymerases accurate calculations imp family metallo-b-lactamases applied pharmacology infectious diseases drug analysis antibiotics pathogenic bacteria bacteria microbial pathogenesis pharmacognosy molecular biology microbiology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Natural-Product-Derived Antimicrobial Adjuvants to Reverse Plasmid-Mediated Bacterial Resistance. Journal of Agricultural and Food Chemistry (2026)

Impact of Synonymous Mutations in the Bla Tem-3 Gene on Gene Expression and Escherichia Coli Fitness. Microbiology Spectrum (2025)

Inhibitor Affinity Differs Among Clinical Variants of Imp Metallo- β -Lactamases: Analysis and Implications for Inhibitor Design. ACS Infectious Diseases (2025)

antimicrobial agentsclinical variantsantimicrobial resistancepharmacologyenzyme inhibitionantibiotic resistanceinhibitor designpharmacotherapymolecular pharmacologyantimicrobial susceptibilityantibioticsinhibitory activitydrug discoverydrug resistance analysisinhibitor affinity differsmicrobiologypharmacological research

Molecular Mechanisms and the Significance of Synonymous Mutations. Biomolecules (2024)

A Dual Covalent Binder for Labelling and Inhibiting Serine and Metallo-Carbapenemases. Chemical Communications (2023)

A Self-Reported Inhibitor of Metallo-Carbapenemases for Reversing Carbapenem Resistance. International Journal of Biological Macromolecules (2023)

Strategies to Name Metallo-β-Lactamases and Number Their Amino Acid Residues. Antibiotics (2023)

Polymorphisms in Common Antihypertensive Targets: Pharmacogenomic Implications for the Treatment of Cardiovascular Disease. Advances in pharmacology (2022)

human polymorphismspharmacologypharmacogenomicscommon antihypertensive targetscardiovascular researchgeneticshypertensionantihypertensive therapypharmacogenomic implicationsgenetic determinantsgenetic epidemiologypharmacological researchcardiovascular disease

Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors. Journal of Medicinal Chemistry (2022)

Monoclonal Antibody Therapy Against Acinetobacter Baumannii. Infection and Immunity (2021)

Travis B. NielsenJun YanMatthew SlarvePeggy LuRachel LiJuan RuizBosul LeeElizabeth BurkYuli TalyanskyPeter OelschlaegerKyle HurthWilliam WinBrian M. LunaRobert A. BonomoBrad Spellberg

immunologymedicinemonoclonal antibody therapyclinical microbiologydrug resistanceinfectious diseases

1
2
3
4
10 / page

Peter Oelschlaeger

Associate Professor

Western University of Health Sciences

Affiliations

College Of Pharmacy

Department Of Pharmaceutical Sciences

Peter Oelschlaeger is currently serving as a College Of Pharmacy Associate Professor at Western University of Health Sciences.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Peter Oelschlaeger

Western University of Health Sciences

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Natural-Product-Derived Antimicrobial Adjuvants to Reverse Plasmid-Mediated Bacterial Resistance. Journal of Agricultural and Food Chemistry (2026)

Impact of Synonymous Mutations in the Bla Tem-3 Gene on Gene Expression and Escherichia Coli Fitness. Microbiology Spectrum (2025)

Inhibitor Affinity Differs Among Clinical Variants of Imp Metallo- β -Lactamases: Analysis and Implications for Inhibitor Design. ACS Infectious Diseases (2025)

Molecular Mechanisms and the Significance of Synonymous Mutations. Biomolecules (2024)

A Dual Covalent Binder for Labelling and Inhibiting Serine and Metallo-Carbapenemases. Chemical Communications (2023)

A Self-Reported Inhibitor of Metallo-Carbapenemases for Reversing Carbapenem Resistance. International Journal of Biological Macromolecules (2023)

Strategies to Name Metallo-β-Lactamases and Number Their Amino Acid Residues. Antibiotics (2023)

Polymorphisms in Common Antihypertensive Targets: Pharmacogenomic Implications for the Treatment of Cardiovascular Disease. Advances in pharmacology (2022)

Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors. Journal of Medicinal Chemistry (2022)

Monoclonal Antibody Therapy Against Acinetobacter Baumannii. Infection and Immunity (2021)

Travis B. NielsenJun YanMatthew SlarvePeggy LuRachel LiJuan RuizBosul LeeElizabeth BurkYuli TalyanskyPeter OelschlaegerKyle HurthWilliam WinBrian M. LunaRobert A. BonomoBrad Spellberg

immunologymedicinemonoclonal antibody therapyclinical microbiologydrug resistanceinfectious diseases

1
2
3
4
10 / page